Answers are grounded in this paper and cite their sources.
Health policy review reveals evidence gaps in Indigenous newborn screening participation, highlighting the need to address community perspectives before integrating genomics.
Australia's newborn bloodspot screening (NBS) program is offered to every newborn. It screens for 34 rare conditions with the potential for hundreds more to be added using genomics. Despite NBS being available in Australia since the 1960s, there is a lack of evidence regarding the participation and experiences of Aboriginal and Torres Strait Islander peoples in NBS. As Australia considers a future where genomics might be used in NBS, there is a critical window of opportunity to understand and prioritise the perspectives, hopes and fears of Aboriginal and Torres Strait Islander peoples regarding the utility of genomics in NBS.
No takes yet. Share an insight, caveat, or question.
Garvey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: